[1]骆峻, 金安娜, 吴旭东, 等.中国人群HLA-DRB1基因多态性与慢性肝炎关系的Meta分析[J].世界华人消化杂志, 2006, 14 (31) :3050-3054.
|
[2]中华医学会.慢性乙型肝炎防治指南[J].实用肝脏病杂志, 2006, 9 (10) :8-18.
|
[3]Olerup O, Zetterquist H.HLA-DR typing by PCR amplifica-tion with sequence-specific primers (PCR-SSP) in2 hours:An alternative to serological DR typing in clinical prac-tice including donor-recipient matching in cadaveric trans-plantations[J].Tissue Antigens, 1992, 39 (1) :225-235.
|
[4]熊平, 扬颖, 龚非力.一种新的HLA-II类基因分型方法—PCR/SSP技术的建立[J].免疫学杂志, 1996, 12 (4) :258-261.
|
[5]刘业云, 龚菁, 史罗明.阿德福韦治疗慢性乙型肝炎患者的疗效观察[J].实用临床医药杂志, 2007, 11 (4) :84.
|
[6]Seigneres B, Aguesse-gemon S, Pichoud C, et al.Duck hep-atitis B virus polymerase gene mutants assosciated with resist-ance to lamivudine have a decreased replication capacity in vitro and in vivo[J].J Hepatol, 2001, 34 (1) :114-122.
|
[7]王昕红, 张光文, 孙立华, 等.阿德福韦酯对慢性乙型肝炎患者外周T淋巴细胞亚群的影响[J].中国现代医生, 2010, 48 (20) :53-54.
|
[8]江军, 蔡雄, 缪晓辉.阿德福韦酯对慢性乙型肝炎患者外周血干扰素和白细胞介素的影响[J].肝脏, 2006, 11 (2) :86-88.
|
[9]Cooksley H, Chokshi S, Maayan Y, et al.Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhandced virus-specific CD4+T-Cell reactivity[J].Antimicrob Agents Chemother, 2008, 52 (1) :312-320.
|
[10]龚非力, 梁薇, 廖纪元, 等.医学免疫学[M].北京:科学出版社, 2007:66-96.
|
[11]王玫, 聂向民, 朱传福, 等.中国山东省威海, 莱芜地区健康人群HLA—A、B、DRB1等位基因频率多态性调查[J].微循环学杂志, 2006, 16 (4) :40-45.
|
[12]黄爱春, 吴继周, 吴健林, 等.HLA-DRB1*14和*15等位基因与肝癌的相关性[J].临床肝胆病杂志, 2010, 26 (4) :240-242.
|